Results 21 to 30 of about 126,328 (301)

Malignant Pleural Effusion: Diagnosis and Management

Canadian Respiratory Journal, 2020
Symptomatic malignant pleural effusion is a common clinical problem. This condition is associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies are contributing evidence on an increasing number of therapeutic options
L. Ferreiro, J. Suárez-Antelo, J. Álvarez-Dobaño, M. Toubes, V. Riveiro, L. Valdés   +5 more
semanticscholar   +1 more source

Thoracic ultrasound for malignant pleural effusion: a systematic review and meta-analysis

ERJ Open Research, 2020
This systematic review aimed to evaluate the diagnostic accuracy of thoracic ultrasound in malignant pleural effusion. Articles published until December 2019 in MEDLINE, Embase, the Cochrane Central Register of Controlled Trials and the International ...
A. Shiroshita, S. Nozaki, Yu Tanaka, Yan Luo, Yuki Kataoka   +4 more
semanticscholar   +1 more source

Can malignant and inflammatory pleural effusions in dogs be distinguished using computed tomography [PDF]

, 2017
Computed tomography (CT) is the primary imaging modality used to investigate human patients with suspected malignant or inflammatory pleural effusion, but there is a lack of information about the clinical use of this test in dogs.
Aquino, Bedford, Benamore, Caivano, Ceribasi, Charney, D'Angelo, Dempsey, Dubielzig, Echandi, Fossum, Gumber, Hirsch, Hung, Kawashima, Lara-Garcia, Metintas, Morrison, Mott, Müller, Nakamura, Prather, Przeździecki, Rebar, Reetz, Sahin, Smith, Swinbourne, Thrall, Traill, Tyler, Vansteenkiste, Vogtli, Waite, Wang, Yamamoto   +35 more
core   +1 more source

Indwelling pleural catheters for non-malignant pleural effusions: report on a single centre's 10 years of experience [PDF]

, 2020
BACKGROUND: Recurrent pleural effusion is a common cause of dyspnoea, cough and chest pain during the course of infectious pleurisy and non-malignant diseases like congestive heart failure (CHF) or liver cirrhosis with hepatic hydrothorax (HH). With
Brünger, Martin, Frost, Nikolaj, Raspe, Matthias, Ruwwe-Glösenkamp, Christoph, Suttorp, Norbert, Temmesfeld-Wollbrück, Bettina, Witzenrath, Martin   +6 more
core   +1 more source

New biomarkers for the diagnosis of pleural effusion

The Egyptian Journal of Bronchology, 2022
Background Persistent undiagnosed effusion is present in approximately 15% of all causes of exudative effusion. Pleural effusion caused by immunoglobulin G4 (IgG4) is a new type of pleural effusion.
Raafat T. El-Sokkary, Nermen M. Abuelkassem, Mohamed Ismail Seddik, Ahmed Metwally   +3 more
doaj   +1 more source

Diagnostic value of procalcitonin and C-reactive protein in differentiation between some benign and malignant pleural

Egyptian Journal of Chest Disease and Tuberculosis, 2014
Pleural effusion is relatively common clinical condition that requires differential diagnosis. It is defined as collection of fluid in pleural space. Pleural effusion is often diagnostic dilemma for the physician.
Wafaa S. El-Shimy, Ghada A. Attia, Sahar M. Hazzaa, Yousef M. Mansour, Walaa M. Abd El-Halim   +4 more
doaj   +1 more source

A clinical study of pleural effusion and its radiological, biochemical, bacteriological and cytological correlation

Journal of Integrated Health Sciences, 2017
Introduction: Pleural effusion refers to excessive or abnormal accumulation of fluid in the pleural space. It is a commonly encountered medical problem caused by a variety of underlying pathological conditions.
N D Khamar, P R Gohil, R N Thacker, U S Gediya   +3 more
doaj   +1 more source

C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusion

Egyptian Journal of Chest Disease and Tuberculosis, 2015
Introduction: Distinction between malignant and non-malignant pleural effusion is of great importance in the patient management. The aim: We examined the diagnostic value of C-reactive protein (CRP) and serum amyloid A (SAA) in distinguishing different ...
Hala Mohamed Shalaby Samaha, Amany Ragab Elsaid, Rasha Elzehery, Rania Elhelaly   +3 more
doaj   +1 more source

Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”

Case Reports in Oncology, 2021
Malignant pleural effusion represents a prognostic negative factor on survival conferring stage IV disease. The median of survival is 5 months and a 5-year survival of about 3%.
Umberto Caterino, Cristiano Cesaro, Enzo Zamparelli, Flavio Cesaro, Alba Palma, Raffaella Lucci, Pasquale Imitazione, Dino Casazza, Dario Amore   +8 more
doaj   +1 more source

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma [PDF]

, 2014
Rationale:. The diagnosis of pleural malignant mesothelioma (MM) by effusion cytology may be difficult and is currently controversial. Effusion mesothelin levels are increased in patients with MM but the clinical role of this test is uncertain ...
Creaney, Jenette, Dick, Ian M., Musk, A. W(Bill), Olsen, Nola, Robinson, Bruce W., Segal, Amanda, Skates, Steven J.   +6 more
core   +2 more sources